A systematic review comparing cisplatin and carboplatin plus paclitaxel-based chemotherapy for recurrent or metastatic cervical cancer-Reference-Cited by-同舟云学术

A systematic review comparing cisplatin and carboplatin plus paclitaxel-based chemotherapy for recurrent or metastatic cervical cancer

Published:2014-04 Issue:1 Volume:133 Page:117-123
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Lorusso Domenica,Petrelli Fausto,Coinu Andrea,Raspagliesi Francesco,Barni Sandro

Publisher

Elsevier BV

Subject

Obstetrics and Gynaecology,Oncology

Reference28 articles.

1. Cancer statistics, 2007;Jemal;CA Cancer J Clin,2007

2. Chemotherapy for recurrent cervical cancer;Cadron;Gynecol Oncol,2007

3. Cis-dichlorodiammineplatiunm (II) in the treatment of gynecologic malignancies: phase II trials by the Gynecologic Oncology Group;Thigpen;Cancer Treat Rep,1979

4. Phase III study of cisplatin with or without paclitaxel in stage IVB, recurrent or persistent squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study;Moore;J Clin Oncol,2004

5. Phase III trial of four cisplatin-containing doublet combinations in stage IVB, recurrent, or persistent cervical carcinoma: a Gynecologic Oncology Group study;Monk;J Clin Oncol,2009

Cited by 171 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A distinct subset of urothelial cells with enhanced EMT features promotes chemotherapy resistance and cancer recurrence by increasing COL4A1-ITGB1 mediated angiogenesis;Drug Resistance Updates;2024-09

2. Análise do perfil de devoluções de quimioterapias endovenosas em um hospital filantrópico de Salvador-BA;Vigilância Sanitária em Debate;2024-07-15

3. Resveratrol in the Treatment of Gynecological Cancer: Mechanisms and Therapeutic Potential;Current Medicinal Chemistry;2024-05-03

4. Vulvar Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology;Journal of the National Comprehensive Cancer Network;2024-03

5. Cadonilimab Combined with Chemotherapy with or without Bevacizumab as First-Line Treatment in Recurrent or Metastatic Cervical Cancer (COMPASSION-13): A Phase 2 Study;Clinical Cancer Research;2024-02-19